Try our beta test site
73 studies found for:    "Primary biliary cirrhosis"
Show Display Options
Rank Status Study
21 Completed Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Biological: NGM282
22 Completed
Has Results
Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Subjects With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Drug: obeticholic acid (OCA)
23 Completed Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Biological: NGM282;   Biological: Placebo
24 Unknown  Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Biological: Biological: mesenchymal stem cell;   Drug: ursodeoxycholic acid
25 Completed Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Drug: UDCA (Ursodeoxycholic acid)
26 Withdrawn An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Drug: LUM001
27 Terminated Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC)
Condition: Primary Biliary Cirrhosis
Interventions: Drug: budesonide;   Drug: budesonide placebo
28 Terminated Study to Evaluate the Effects of Two Doses of MBX-8025 in Subjects With Primary Biliary Cirrhosis (PBC)
Condition: Primary Biliary Cirrhosis (PBC)
Interventions: Drug: Placebo Comparator;   Drug: Experimental: MBX-8025 50 mg;   Drug: Experimental: MBX-8025 200 mg
29 Recruiting MBX-8025 in Subjects With Primary Biliary Cholangitis (PBC) (8 Week, Dose Ranging, Open Label, Randomized Phase 2 With an Extension)
Condition: Primary Biliary Cirrhosis
Interventions: Drug: MBX-8025 5 mg Capsule;   Drug: MBX-8025 10 mg Capsule;   Drug: MBX-8025 25 mg Capsule
30 Completed B-Cell Depleting Therapy (Rituximab) as a Treatment for Fatigue in Primary Biliary Cirrhosis
Conditions: Fatigue;   Primary Biliary Cirrhosis
Interventions: Biological: Rituximab;   Other: Placebo
31 Recruiting Nalfurafine Hydrochloride for Pruritus in Patients With Primary Biliary Cholangitis
Condition: Primary Biliary Cirrhosis
Intervention:
32 Completed Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis
Conditions: Primary Biliary Cirrhosis;   Hypercholesterolemia
Intervention: Drug: Atorvastatin
33 Completed Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis (PBC)
Conditions: Fatigue;   Primary Biliary Cirrhosis
Intervention: Drug: Modafinil
34 Withdrawn Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune Hepatitis
Conditions: Primary Biliary Cirrhosis;   Autoimmune Hepatitis
Intervention: Drug: Budesonide
35 Completed
Has Results
Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis
Conditions: PBC;   Primary Biliary Cirrhosis
Interventions: Drug: LUM001;   Drug: Placebo;   Drug: Ursodeoxycholic Acid
36 Terminated Primary Biliary Cirrhosis: Investigating A New Treatment Option Using NI-0801, an Anti-CXCL10 Monoclonal Antibody
Condition: Primary Biliary Cirrhosis
Intervention: Drug: NI-0801
37 Recruiting Fuzhenghuayu in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Fuzhenghuayu;   Drug: UDCA
38 Recruiting Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid
Condition: Primary Biliary Cirrhosis
Interventions: Drug: Fenofibrate;   Drug: UDCA
39 Recruiting Pilot Study of FFP104 Dose Escalation in PBC Subjects
Condition: Primary Biliary Cirrhosis
Intervention: Drug: FFP104
40 Recruiting Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid
Condition: Primary Biliary Cholangitis
Interventions: Drug: E6011;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.